Price $4.42 |
Market Cap
126.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
14.5
|
P/B
-
|
P/S
1.72
|
Dividend %
-
|
|
P/CF
9.5
|
P/FCF
-
|
Op. Cash Flow
17.8K
|
FCF
-
|
|
Op. Margin
24.80%
|
Net Margin
16.70%
|
ROE
-15.90%
|
ROI
39.00%
|
|
ROA
13.70%
|
EPS Growth
120.20%
|
Current Ratio
3.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Genesis Healthcare Inc (GENN) | $0.19 | - | - | 29.3M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.56 | - | - | 68.5M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $62.46 | - | 3.50% | 138.77B | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.20 | - | - | 6M | Strong Buy |
| Castlight Health Inc (CSLT) | $2.04 | - | - | 251.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
